FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094174953> ?p ?o ?g. }

• W2094174953 endingPage "e114374" @default.
• W2094174953 startingPage "e114374" @default.
• W2094174953 abstract "Smallpox vaccine based on live, replicating vaccinia virus (VACV) is associated with several potentially serious and deadly complications. Consequently, a new generation of vaccine based on non-replicating Modified vaccinia virus Ankara (MVA) has been under clinical development. MVA seems to induce good immune responses in blood tests, but it is impossible to test its efficacy in vivo in human. One of the serious complications of the replicating vaccine is eczema vaccinatum (EV) occurring in individuals with atopic dermatitis (AD), thus excluding them from all preventive vaccination schemes. In this study, we first characterized and compared development of eczema vaccinatum in different mouse strains. Nc/Nga, Balb/c and C57Bl/6J mice were epicutaneously sensitized with ovalbumin (OVA) or saline control to induce signs of atopic dermatitis and subsequently trans-dermally (t.d.) immunized with VACV strain Western Reserve (WR). Large primary lesions occurred in both mock- and OVA-sensitized Nc/Nga mice, while they remained small in Balb/c and C57Bl/6J mice. Satellite lesions developed in both mock- and OVA-sensitized Nc/Nga and in OVA-sensitized Balb/c mice with the rate 40-50%. Presence of mastocytes and eosinophils was the highest in Nc/Nga mice. Consequently, we have chosen Nc/Nga mice as a model of AD/EV and tested efficacy of MVA and Dryvax vaccinations against a lethal intra-nasal (i.n.) challenge with WR, the surrogate of smallpox. Inoculation of MVA intra-muscularly (i.m.) or t.d. resulted in no lesions, while inoculation of Dryvax t.d. yielded large primary and many satellite lesions similar to WR. Eighty three and 92% of mice vaccinated with a single dose of MVA i.m. or t.d., respectively, survived a lethal i.n. challenge with WR without any serious illness, while all Dryvax-vaccinated animals survived. This is the first formal prove of protective immunity against a lethal poxvirus challenge induced by vaccination with MVA in an atopic organism." @default.
• W2094174953 created "2016-06-24" @default.
• W2094174953 creator A5009952882 @default.
• W2094174953 creator A5012644644 @default.
• W2094174953 creator A5033932983 @default.
• W2094174953 creator A5036721132 @default.
• W2094174953 creator A5050869811 @default.
• W2094174953 creator A5074111831 @default.
• W2094174953 date "2014-12-08" @default.
• W2094174953 modified "2023-10-14" @default.
• W2094174953 title "Development of Eczema Vaccinatum in Atopic Mouse Models and Efficacy of MVA Vaccination against Lethal Poxviral Infection" @default.
• W2094174953 cites W1546445911 @default.
• W2094174953 cites W1562702833 @default.
• W2094174953 cites W1960031454 @default.
• W2094174953 cites W1964911420 @default.
• W2094174953 cites W1966390535 @default.
• W2094174953 cites W1970140945 @default.
• W2094174953 cites W1975349667 @default.
• W2094174953 cites W1975769870 @default.
• W2094174953 cites W1982895831 @default.
• W2094174953 cites W1988351609 @default.
• W2094174953 cites W1994399275 @default.
• W2094174953 cites W2001510915 @default.
• W2094174953 cites W2002797131 @default.
• W2094174953 cites W2005188784 @default.
• W2094174953 cites W2021643601 @default.
• W2094174953 cites W2022205289 @default.
• W2094174953 cites W2024392143 @default.
• W2094174953 cites W2026893238 @default.
• W2094174953 cites W2029788006 @default.
• W2094174953 cites W2035550266 @default.
• W2094174953 cites W2037027989 @default.
• W2094174953 cites W2039603982 @default.
• W2094174953 cites W2040865227 @default.
• W2094174953 cites W2047391267 @default.
• W2094174953 cites W2049286784 @default.
• W2094174953 cites W2051300784 @default.
• W2094174953 cites W2055817487 @default.
• W2094174953 cites W2062062335 @default.
• W2094174953 cites W2067594212 @default.
• W2094174953 cites W2067968059 @default.
• W2094174953 cites W2070177503 @default.
• W2094174953 cites W2072087913 @default.
• W2094174953 cites W2074548951 @default.
• W2094174953 cites W2081022718 @default.
• W2094174953 cites W2087109205 @default.
• W2094174953 cites W2089577632 @default.
• W2094174953 cites W2091729488 @default.
• W2094174953 cites W2092264542 @default.
• W2094174953 cites W2093462119 @default.
• W2094174953 cites W2096279219 @default.
• W2094174953 cites W2103229419 @default.
• W2094174953 cites W2104075561 @default.
• W2094174953 cites W2107726313 @default.
• W2094174953 cites W2116738479 @default.
• W2094174953 cites W2138718028 @default.
• W2094174953 cites W2139043919 @default.
• W2094174953 cites W2150145564 @default.
• W2094174953 cites W2158437004 @default.
• W2094174953 cites W2159964381 @default.
• W2094174953 cites W2172039135 @default.
• W2094174953 cites W2419231299 @default.
• W2094174953 cites W298232703 @default.
• W2094174953 cites W4232510995 @default.
• W2094174953 cites W4238468398 @default.
• W2094174953 cites W4292122650 @default.
• W2094174953 doi "https://doi.org/10.1371/journal.pone.0114374" @default.
• W2094174953 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4259321" @default.
• W2094174953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25486419" @default.
• W2094174953 hasPublicationYear "2014" @default.
• W2094174953 type Work @default.
• W2094174953 sameAs 2094174953 @default.
• W2094174953 citedByCount "8" @default.
• W2094174953 countsByYear W20941749532017 @default.
• W2094174953 countsByYear W20941749532018 @default.
• W2094174953 countsByYear W20941749532019 @default.
• W2094174953 countsByYear W20941749532020 @default.
• W2094174953 countsByYear W20941749532021 @default.
• W2094174953 countsByYear W20941749532023 @default.
• W2094174953 crossrefType "journal-article" @default.
• W2094174953 hasAuthorship W2094174953A5009952882 @default.
• W2094174953 hasAuthorship W2094174953A5012644644 @default.
• W2094174953 hasAuthorship W2094174953A5033932983 @default.
• W2094174953 hasAuthorship W2094174953A5036721132 @default.
• W2094174953 hasAuthorship W2094174953A5050869811 @default.
• W2094174953 hasAuthorship W2094174953A5074111831 @default.
• W2094174953 hasBestOaLocation W20941749531 @default.
• W2094174953 hasConcept C104317684 @default.
• W2094174953 hasConcept C159047783 @default.
• W2094174953 hasConcept C203014093 @default.
• W2094174953 hasConcept C22070199 @default.
• W2094174953 hasConcept C2776946954 @default.
• W2094174953 hasConcept C2777760223 @default.
• W2094174953 hasConcept C2778329239 @default.
• W2094174953 hasConcept C2779272165 @default.
• W2094174953 hasConcept C2781356689 @default.
• W2094174953 hasConcept C40767141 @default.
• W2094174953 hasConcept C55493867 @default.

• next